Health Care
JD Health IPO helps cure Hong Kong market blues after Ant
City's new listings haul for this year set to be highest since 2010
Health Care & Pharma
Coronavirus
AstraZeneca says 'vaccine for the world' can be 90% effective
UK drugmaker promises up to 200m doses by end of year
Coronavirus
Japan takes different track than US on COVID-19 antibody treatments
Takeda alliance focuses on therapy derived from patients' blood
Markets
Health spa operator readies Japan Inc.'s first US-only IPO in 21 years
Medirom looks to raise $20m in Nasdaq debut next month
Coronavirus
Moderna to charge $25-$37 for COVID-19 vaccine
US company close to deal with European Commission, CEO tells German paper
Pharmaceuticals
Pfizer applies for US emergency use for COVID-19 vaccine
Company rushes enough doses for 25m people as it expects mid-December approval
Markets
China's Fosun-owned pharma jumps 21% in India market debut
Gland Pharma goes public amid prolonged border tensions between two countries
Pharmaceuticals
WHO advises not to give Gilead's remdesivir to COVID patients
Large trial shows no evidence the US company's drug improves survival, panel says
Business Spotlight
Unicharm takes on COVID-19 and rivals with 'made in Japan' masks
CEO wants to sell to Indonesia and Thailand to build on success with diapers
Pharmaceuticals
Celltrion spends $450m to ramp up contract drug production
South Korean pharma maker seeks to tap booming overseas demand
